ID
38180
Description
Study ID: 110951 Clinical Study ID: 110951 Study Title: A two-part, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of intravenously infused GSK1995057 in healthy subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01476046 See https://clinicaltrials.gov/ct2/show/NCT01476046 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: N/A, Placebo Trade Name: N/A Study Indication: Respiratory Disorders The single-centre study consists of two parts A and B with seven cohorts/ten subcohorts in total. Part A includes ascending doses of the investigational product given to subjects negative or positive for pre-existing human anti-heavy chain variable domain (HAVH) antibodies (Cohorts 1 to 3 with Subcohorts 1a, 2a and 3a negative for HAVH and 1b, 2b, 3b positive for HAVH). Part B includes only subjects negative for HAVH, with ascending doses given to Cohorts 4 to 6. Cohort 7 receives the same dose as Cohort 6, but whereas the other Cohorts are single-blinded, Cohort 7 is open-label and additionally receives a bronchoalveolar lavage (BAL). The study consists of a Screening Visit (up to 56 days before Day 1, the day of the drug administration), Visits on Day -1, 1, 2, 3, 5, 7, 14, 28 and Follow-Up Visits on Day 57 and 85. This form contains information on the 12 lead ECG, which is recorded at Screening, on Days 1, 3, 5, 7, 14, 28, in case of early withdrawal and as an unscheduled (repeat) assessment.
Lien
https://clinicaltrials.gov/ct2/show/NCT01476046
Mots-clés
Versions (1)
- 24/09/2019 24/09/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
24 septembre 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Phase I Trial of Intravenous TNFR1 Antagonist GSK1995057 in Healthy Subjects - NCT01476046
12 Lead ECG
- StudyEvent: ODM
Description
Dosing Date and Time
Alias
- UMLS CUI-1
- C0178602
- UMLS CUI-2
- C1264639
Description
ECG
Alias
- UMLS CUI-1
- C1623258
Description
On Day 1, record ECGs at the following times (identical for all Parts/Cohorts/Subcohorts). Fill in the entire repeating itemgroup once per ECG.
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C3469597
- UMLS CUI [1,3]
- C0304229
Description
At Screening, record three ECGs (Measurements 1 to 3). Fill in for repeat ECGs if necessary. Fill in the entire repeating itemgroup once per ECG.
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C0449788
Description
ECG Date / Time
Type de données
datetime
Alias
- UMLS CUI [1]
- C2826846
Description
Heart Rate
Type de données
integer
Unités de mesure
- beats/min
Alias
- UMLS CUI [1]
- C0018810
Description
PR Interval
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1]
- C0429087
Description
QRS Duration
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1]
- C0429025
Description
QT Interval
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1]
- C1287082
Description
i.e. by machine. hidden
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C2911685
- UMLS CUI [1,3]
- C1882513
Description
i.e. manual hidden
Type de données
text
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C2911685
- UMLS CUI [1,3]
- C0470187
- UMLS CUI [1,4]
- C0489636
Description
if applicable
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C1882513
Description
if applicable
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1,1]
- C0489636
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C0855331
Description
if 3 = Abnormal - Clinically significant: complete the ECG abnormality form for all clinically significant abnormalities, and additionally complete the AE form if the abnormality meets the protocol definition for an AE
Type de données
integer
Alias
- UMLS CUI [1]
- C0438154
Similar models
12 Lead ECG
- StudyEvent: ODM
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,2])
C2911685 (UMLS CUI [1,2])
C1882513 (UMLS CUI [1,3])
C2911685 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0489636 (UMLS CUI [1,4])
C1882513 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
C0855331 (UMLS CUI [1,3])